Procept Biorobotics Corp PRCT

$20.30 +0.10 (0.50%)

Valuation

Market cap
1,156,935,000
Revenue TTM
$308,050,000
Net income TTM
$-95,570,000
PE ratio
0.00
Forward PE
—
Profit margin
-31.02%
Debt to equity
0.15

Trading

Volume
704,500
Avg volume
1,203,488
Day's range
$20.06 – $20.67
Shares out
57,274,000
Stochastic %K
88%
Beta
0.92
Analysts
Sell
Price target
$22.33

Price

Company profile

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquabl...

Show more

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Industry
Medical Devices
Sector
Healthcare
Phone
650 232 7200
Website
https://www.procept-biorobotics.com
Address
150 Baytech Drive, San Jose, United States

Latest news

Stocktwits

NEWBIGTECH Oct 27, 3:01 PM 0 replies
BioTechHealthX Oct 25, 7:51 AM
$PRCT PROCEPT BioRobotics Corporation (NASDAQ: PRCT) grew Q2 2026 revenue 19% to $94.5 million. Explore Aquablation demand, procedure growth, and its profitability test. https://biotechhealthx.com/biotech-news/procept-biorobotics-prct-grows-revenue-19-as-surgical-robots-get-busier/
0 replies
BioTechHealthX Oct 25, 7:01 AM
$OUST $PRCT $RR $SERV $VPG From cancer research to intelligent machines, explore 5 biotech stocks, including a developer that raised $200 million to advance its pipeline. https://biotechhealthx.com/biotech-news/5-promising-small-cap-biotech-stocks-to-watch/
1 replies
waugusti Oct 23, 10:53 AM
$PRCT is a nice turnaround story plus buyout possibility. Easy going to 44 us$.
0 replies
Startersorder Oct 14, 5:52 PM
$PRCT if you are not buying down here @$17.50, then you have not done your homework. For a company growing at 20% per year and expecting that to accelerate into cancer treatment. The recent Barclays industry survey shows you what practitioners are thinking and what the international opportunity is…. Buy on these dips…. It is a bargain. This will sky rocket by the end of the year. If not, stop reading my posts.
1 replies
Startersorder Oct 14, 4:14 PM
$PRCT massively undervalued for a growth stock. The cheapest medtech company out there at the moment. Blow away opportunity.
0 replies
px9 Oct 10, 5:03 AM
Been counting $PRCT waves for months, reading every filing. Went in Friday at the close. Why👇 7th Aug : CEO bought $498K while Wall St downgraded. I joined him today 🎯 🟢 Bought $18.41 ➕ Adding $16.80–18 🛑 Stop $16.50 🎯 Half at $22.40, rest $26.50 📉 -84% from $103. Handpiece sales ran 8–16% ahead of real procedures (company's own numbers). 3 drops: -13%, -10%, -15%. 🧹 New CEO from Edwards TAVR cleared inventory and killed the quarter-end incentives. Q2: revenue +19%, guidance held at $390–410M. 💰 Aug 7: CEO buys $498K at ~$20.85 🏦 Oct 6: Barclays Overweight, $30 🤔 🗓️ New CEO hired Jul 24, 2025. Low hit Jul 24, 2026. Reset year done? I think so 📐 Wave 2 held $16.75, 8¢ above the $16.67 base 💪 $231M cash vs $52M debt ✅ Passed my own filters: 7/7 🩳 ~13% of shares short 👀 Close above $18.67 confirms. Q3 ~Nov 3 Could be wrong. The risk is defined. 📌 In May I bought $SHOP at $95, $1 off the low. The stop nearly hit. Sticking to the rules won it, not me. Not advice 🫡 Do your own DD🚨
0 replies
px9 Oct 10, 3:19 AM
As I told you before MY $SHOP entry, late nights is a key for cleaning entries . $PRCT position secured.
2 replies